She is chair and chief executive officer (CEO) of Accenture, a multinational professional services company. [3] The New York Times and Fortune have named her among the most powerful women in corporate America, crediting her for "working on creating true gender equality at …

Julie Sweet is chair and chief executive officer of Accenture. She became CEO in September 2019 and assumed the additional position of chair in September 2021. Previously, she served as chief executive officer of Accenture's business in North America, the company's largest geographic market.

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

2 days ago · Today, Accenture plc (NYSE: ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a ...

Apr 4, 2024 · Sweet denied ever publicly “shaming” Lacy and said she “politely” asked him to stop his presentation at a global management committee meeting in May 2022, according to Accenture’s defence filing.

1 day ago · Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

2 days ago · Accenture Chief Executive Officer Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, Moneycontrol has learnt. “I was very recently ...

Julie Sweet is chair and chief executive officer of Accenture. She became CEO in September 2019 and assumed the additional position of chair in September 2021. Previously, she served as chief executive officer of Accenture's business in North America, the company's largest geographic market.

1 day ago · Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness. STAYING TRANSPARENT. The cancer was caught early and is curable, the executive told staff and shareholders this week.